Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy Participants

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

ICON Clinical Research: Lenexa, Lenexa, Kansas, United States
ICON Clinical Research: Salt Lake City, Salt Lake City, Utah, United States

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated

Healthy

Abroad (travel likely)RecruitingPHASE1

Berlin, Germany

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.

Healthy Participants · Obesity

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Brooklyn, United States

A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Auckland, New Zealand

A Study to Evaluate the Safety of Increasing Doses of DF5112 in Healthy Adults

Healthy Participants · Healthy Adult Females · Healthy Adult Male

Abroad (travel likely)RecruitingPHASE1

Sydney, Australia